fidarestat has been researched along with Injury, Ischemia-Reperfusion in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agardh, CD; Agardh, E; Obrosova, IG; Smith, ML | 1 |
| Agardh, CD; Agardh, E; El-Remessy, AB; Maksimchyk, Y; Obrosova, IG; Pacher, P; Smith, ML | 1 |
| Cheung, AK; Chung, SK; Chung, SS; Lo, AC; So, KF | 1 |
3 other study(ies) available for fidarestat and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
The aldose reductase inhibitor fidarestat suppresses ischemia-reperfusion-induced inflammatory response in rat retina.
Topics: Aldehyde Reductase; Animals; Female; Gene Expression; Imidazolidines; Inflammation; Intercellular Adhesion Molecule-1; Rats; Rats, Wistar; Reperfusion Injury; Retina; Tumor Necrosis Factor-alpha | 2009 |
Evaluation of the aldose reductase inhibitor fidarestat on ischemia-reperfusion injury in rat retina.
Topics: Aldehyde Reductase; Animals; Apoptosis; Blotting, Western; Drug Evaluation, Preclinical; Female; Fructose; Glucose; Imidazolidines; Immunohistochemistry; In Situ Nick-End Labeling; Injections, Intravenous; L-Iditol 2-Dehydrogenase; Rats; Rats, Wistar; Reperfusion Injury; Retina; Sorbitol | 2010 |
Gene deletion and pharmacological inhibition of aldose reductase protect against retinal ischemic injury.
Topics: Aldehyde Reductase; Animals; Apoptosis; Gene Deletion; Glutamic Acid; Imidazolidines; L-Iditol 2-Dehydrogenase; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neuroglia; Oxidative Stress; Papilledema; Pyrimidines; Reperfusion Injury; Retinal Diseases; Retinal Ganglion Cells | 2007 |